Skip to main content
Log in

Histone H1S-3 phosphorylation in Ha-ras oncogene-transformed mouse fibroblasts

  • Original Paper
  • Published:
Oncogene Submit manuscript

Abstract

Phosphorylation of linker histone H1S-3 (previously named H1b) and core histone H3 is elevated in mouse fibroblasts transformed with oncogenes or constitutively active mitogen-activated protein kinase (MAPK) kinase (MEK). H1S-3 phosphorylation is the only histone modification known to be dependent upon transcription and replication. Our results show that the increased amounts of phosphorylated H1S-3 in the oncogene Ha-ras-transformed mouse fibroblasts was a consequence of an elevated Cdk2 activity rather than the reduced activity of a H1 phosphatase, which our studies suggest is PP1. Induction of oncogenic ras expression results in an increase in H1S-3 and H3 phosphorylation. However, in contrast to the phosphorylation of H3, which occurred immediately following the onset of Ras expression, there was a lag of several hours before H1S-3 phosphorylation levels increased. We found that there was a transient increase in the levels of p21cip1, which inhibited the H1 kinase activity of Cdk2. Cdk2 activity and H1S-3 phosphorylated levels increased after p21cip1 levels declined. Our studies suggest that persistent activation of the Ras-MAPK signal transduction pathway in oncogene-transformed cells results in deregulated activity of kinases phosphorylating H3 and H1S-3 associated with transcribed genes. The chromatin remodelling actions of these modified histones may result in aberrant gene expression.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  • Bottazzi ME, Zhu X, Bohmer RM, Assoian RK . 1999 J. Cell Biol. 146: 1255–1264

  • Chadee DN, Allis CD, Wright JA, Davie JR . 1997 J. Biol. Chem. 272: 8113–8116

  • Chadee DN, Hendzel MJ, Tylipski CP, Allis CD, Bazett-Jones DP, Wright JA, Davie JR . 1999 J. Biol. Chem. 274: 24914–24920

  • Chadee DN, Taylor WR, Hurta RAR, Allis CD, Wright JA, Davie JR . 1995 J. Biol. Chem. 270: 20098–20105

  • Crissman HA, Gadbois DM, Tobey RA, Bradbury EM . 1991 Proc. Natl. Acad. Sci. USA 88: 7580–7584

  • Egan SE, McClarty GA, Jarolim L, Wright JA, Spiro I, Hager G, Greenberg AH . 1987 Mol. Cell Biol. 7: 830–837

  • Gadbois DM, Crissman HA, Tobey RA, Bradbury EM . 1992a Proc. Natl. Acad. Sci. USA 89: 8626–8630

  • Gadbois DM, Hamaguchi JR, Swank RA, Bradbury EM . 1992b Biochem. Biophys. Res. Commun. 184: 80–85

  • Haliotis T, Trimble W, Chow S, Bull S, Mills G, Girard P, Kuo JF, Hozumi N . 1990 Int. J. Cancer 45: 1177–1183

  • Herrera RE, Chen F, Weinberg RA . 1996 Proc. Natl. Acad. Sci. USA 93: 11510–11515

  • Kivinen L, Tsubari M, Haapajarvi T, Datto MB, Wang XF, Laiho M . 1999 Oncogene 18: 6252–6261

  • Kraemer PM, Bradbury EM . 1993 Exp. Cell Res. 207: 206–210

  • Laitinen J, Sistonen L, Alitalo K, Holtta E . 1990 J. Cell. Biol. 111: 9–17

  • Laitinen J, Sistonen L, Alitalo K, Holtta E . 1994 J. Cell Biochem. 57: 1–11

  • Lee HL, Archer TK . 1998 EMBO J. 17: 1454–1466

  • Lennox RW, Oshima RG, Cohen LH . 1982 J. Biol. Chem. 257: 5183–5189

  • Lu MJ, Dadd CA, Mizzen CA, Perry CA, McLachlan DR, Annunziato AT, Allis CD . 1994 Chromosoma 103: 111–121

  • Mahadevan LC, Willis AC, Barratt MJ . 1991 Cell 65: 775–783

  • Mello MLS, Chambers AF . 1994 Anal. Quant. Cytol. Histol. 16: 2 113–123

  • Parseghian MH, Hamkalo BA . 2001 Biochem. Cell Biol. 79: 289–304

  • Parseghian MH, Newcomb RL, Winokur ST, Hamkalo BA . 2000 Chromosome Res. 8: 405–424

  • Paulson JR, Patzlaff JS, Vallis AJ . 1996 J. Cell Sci. 109: 1437–1447

  • Roovers K, Assoian RK . 2000 BioEssays 22: 818–826

  • Roth SY, Allis CD . 1992 Trends Biochem. Sci. 17: 93–98

  • Strelkov IS, Davie JR . 2002 Cancer Res. 62: 75–78

  • Tan KB, Borun TW, Charpentier R, Cristofalo VJ, Croce CM . 1982 J. Biol. Chem. 257: 5337–5338

  • Taylor WR, Chadee DN, Allis CD, Wright JA, Davie JR . 1995 FEBS Lett. 377: 51–53

  • Tuck AB, Wilson SM, Khokha R, Chambers AF . 1991 J. Natl. Cancer Inst. 83: 485–491

  • Wright JA, Egan SE, Greenberg AH . 1994 Anticancer Res. 10: 1247–1256

Download references

Acknowledgements

This research was supported by a grant from the National Cancer Institute of Canada with funds from the Canadian Cancer Society. A Canadian Institutes of Health Research Senior Scientist to JR Davie is also gratefully acknowledged.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to James R Davie.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chadee, D., Peltier, C. & Davie, J. Histone H1S-3 phosphorylation in Ha-ras oncogene-transformed mouse fibroblasts. Oncogene 21, 8397–8403 (2002). https://doi.org/10.1038/sj.onc.1206029

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1206029

  • Springer Nature Limited

Keywords

This article is cited by

Navigation